Results 1 to 10 of about 8,385 (178)

Preventing invasive meningococcal disease in early infancy

Human Vaccines & Immunotherapeutics, 2022
This review considers the pathogenesis, diagnosis, and epidemiology of invasive meningococcal disease in infants, to examine and critique meningococcal disease prevention in this population through vaccination.
Jessica Presa, Lidia Serra, Catherine Weil-Olivier, Laura York   +3 more
doaj   +3 more sources

Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

Infection and Drug Resistance, 2011
Michael Bröker, Brian Cooper, Lisa M DeTora, Jeffrey J StoddardGlobal Medical Affairs, Novartis Vaccines and Diagnostics, Marburg, Germany, and Cambridge, MA, USAAbstract: Worldwide, invasive meningococcal disease affects about 500,000 people ...
Bröker M, Cooper B, DeTora LM, Stoddard JJ   +3 more
doaj   +2 more sources

Population-based study of influenza and invasive meningococcal disease among Greek children during the COVID-19 pandemic

BMJ Paediatrics Open, 2022
Background Aiming to the containment of the coronavirus disease 2019 (COVID-19) pandemic, governments worldwide have implemented a series of non-pharmaceutical interventions.
Theoklis Zaoutis, Vassiliki Papaevangelou, Danai Ktena, Eleni Kourkouni, Flora Kontopidou, Kassiani Gkolfinopoulou, Kalliopi Papadima, Theano Georgakopoulou, Ioanna Magaziotou, Anastasia Andreopoulou, Georgina Tzanakaki   +10 more
doaj   +1 more source

Fatal Waterhouse-Friderichsen syndrome due to Neisseria meningitidis group B in a paediatric patient during the phone consultation era

Pediatria Polska, 2023
Owing to uncharacteristic initial symptoms and rapid progression, invasive meningococcal disease is still a challenge to diagnose and treat, even in high-income countries.
Marta Serafin, Ewa Czerwińska, Marian Koźbiał, Mariusz Leszczyński, Leszek Szenborn   +4 more
doaj   +1 more source

Invasive Meningococcal X Disease during the COVID-19 Pandemic, Brazil

Emerging Infectious Diseases, 2022
Invasive meningococcal disease persists as a fulminant disorder worldwide. Although cases caused by Neisseria meningitidis serogroup X (MenX) occur infrequently, outbreaks have been reported in countries in Africa in recent decades. We report 2 cases of
Lucila O. Fukasawa, Bernadete L. Liphaus, Maria Gisele Gonçalves, Fabio T. Higa, Carlos H. Camargo, Telma R.M.P. Carvalhanas, Ana Paula S. Lemos   +6 more
doaj   +1 more source

Epidemiological Characteristics of Meningococcal Infection in Moscow

Эпидемиология и вакцинопрофилактика, 2020
Aims. The purpose of this study was to identify current epidemiological features of meningococcal infection in Moscow.Materials and methods. Cases of invasive meningococcal disease in Moscow from 2014 to 2018 and the biomaterial from patients with an ...
M. I. Gritsay, M. A. Koroleva, N. N. Fomkina, I. S. Koroleva   +3 more
doaj   +1 more source

Nonspecific symptoms dominate at first contact to emergency healthcare services among cases with invasive meningococcal disease

BMC Family Practice, 2021
Background An early appropriate response is the cornerstone of treatment for invasive meningococcal disease. Little evidence exists on how cases with invasive meningococcal disease present at first contact to emergency medical services.
Nichlas Hovmand, Helle Collatz Christensen, Lene Fogt Lundbo, Håkon Sandholdt, Gitte Kronborg, Perle Darsø, Jacob Anhøj, Stig Nikolaj Fasmer Blomberg, Asmus Thun Bisgaard, Thomas Benfield   +9 more
doaj   +1 more source

Recommendations of the Polish Paediatric Society, the Polish Society of Vaccinology, and the Polish Society of Family Medicine on meningococcal vaccinations in children and adults in Poland

Pediatria Polska, 2022
Invasive meningococcal disease is a dangerous bacterial infection that often leads to death or permanent disability. Immunization is the best strategy to protect individuals against invasive infections caused by Neisseria meningitidis.
Ernest Kuchar, Hanna Czajka, Ewelina Gowin, Aneta Nitsch-Osuch, Anna Skoczyńska, Leszek Szenborn, August Wrotek, Jacek Wysocki, Agnieszka Mastalerz-Migas, Jarosław Peregud-Pogorzelski, Teresa Jackowska   +10 more
doaj   +1 more source

Neisseria meningitidis pneumonia with bacteremia without meningitis: An atypical presentation

IDCases, 2020
Neisseria meningitidis remains the most important cause of bacterial meningitis worldwide. The second most common and potentially severe end-organ manifestation of invasive meningococcal disease is meningococcal pneumonia.
Fatma Mohamed Mahmoud, Thana Harhara
doaj   +1 more source

Exploring the Ability of Meningococcal Vaccines to Elicit Mucosal Immunity: Insights from Humans and Mice

Pathogens, 2021
Neisseria meningitidis causes a devastating invasive disease but is also a normal colonizer of the human nasopharynx. Due to the rapid progression of disease, the best tool to protect individuals against meningococcal infections is immunization. Clinical
Elissa G. Currie, Scott D. Gray-Owen
doaj   +1 more source